HALO logo
halo search icon
CRISPR Therapeutics AG
CRISPR Therapeutics AG
CRSP · NAS

CRISPR Therapeutics AG

US$48.55

Price Arrow0.96 (2.02%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

CRISPR Therapeutics AG Overview

CRSP Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Neutral

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Strong

About CRSP

icon

Telephone

41.41.561.32.77

icon

Address

Baarerstrasse 14, Zug 6300

Description

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRSP Price Chart

Key Stats

Market Cap

US$4.59B

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 35.38 - 78.48

Trade Value (12mth)

US$32,650,457.00

1 week

-1.69%

1 month

-14.31%

YTD

-11.49%

1 year

28.66%

All time high

220.20

Key Fundamentals

EPS 3 yr Growth

-22.70%

EBITDA Margin

NaN%

Operating Cashflow

-$345m

Free Cash Flow Return

-16.20%

ROIC

-27.40%

Interest Coverage

0.00

Quick Ratio

13.30

Other Data

Shares Outstanding (Fully Diluted)

96m

HALO Sector

Healthcare

Next Company Report Date

16-Feb-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

CRSP Announcements

Latest Announcements

DateAnnouncements
05 May 26
05 May 26
05 May 26
05 May 26
11 March 26

CRSP Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.94-4.34-6.47locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.94-4.34-6.47locklocklock
Growth
%locklocklocklock76.8-123.9-49locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of CRISPR Therapeutics AG (CRSP:NAS)?
Halo FAQ
The current share price of CRISPR Therapeutics AG (CRSP:NAS) is USD$48.55.
What is the 52-week high share price for CRISPR Therapeutics AG (CRSP:NAS)?
Halo FAQ
The 52-week high share price for CRISPR Therapeutics AG (CRSP:NAS) is USD$78.48.
What is the 52-week low share price for CRISPR Therapeutics AG (CRSP:NAS)?
Halo FAQ
The 52-week low share price for CRISPR Therapeutics AG (CRSP:NAS) is USD$35.38.
What is the dividend yield for CRISPR Therapeutics AG (CRSP:NAS)?
Halo FAQ
CRISPR Therapeutics AG (CRSP:NAS) does not pay a dividend.
What was CRISPR Therapeutics AG (CRSP:NAS) last dividend payment?
Halo FAQ
CRISPR Therapeutics AG (CRSP:NAS) does not pay a dividend.
What is the franking level for CRISPR Therapeutics AG (CRSP:NAS)?
Halo FAQ
CRISPR Therapeutics AG (CRSP:NAS) has a franking level of 0.00%.
In which sector is CRISPR Therapeutics AG (CRSP:NAS) classified?
Halo FAQ
CRISPR Therapeutics AG (CRSP:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.